compounded semaglutide and tirzepatide Program: Results, Timeline & Comparison Important Update: Compounded Tirzepatide Phasing

71 : 504519 Pettegrew JW, Short JW, Woessner RD, Strychor S, McKeag DW, Armstrong J et al

Most patients regain a portion of the weight if they stop without a structured maintenance plan

Compounded versions of semaglutide are not FDA-approved products, though the active ingredient itself has FDA approval for weight management through brand-name formulations

The exception was higher BMI, which showed a stronger association with lower discontinuation rates among GLP-1 receptor agonist users than SGLT2 inhibitor users

SDOH are defined as the economic, environmental, political, and social conditions in which people live and are responsible for a major part of health inequality worldwide